Vaccines are essential in campaigns against HIV and TB, say researchersBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e3625 (Published 22 May 2012) Cite this as: BMJ 2012;344:e3625
- Peter Moszynski
Major breakthroughs in the development of vaccines against HIV and tuberculosis over the past decade have resulted in a number of promising candidates entering late stage clinical trials. Yet participants at a symposium held last week by the UK Consortium on AIDS and International Development warned that this progress could be jeopardised by the recent downturn in global health funding.
The meeting heard that currently 71 HIV vaccine trials and 15 trials of tuberculosis vaccines are ongoing.
Robin Shattock, of Imperial College London, said that one HIV vaccine candidate, RV144, had recently completed stage III trials in Thailand, showing a protective efficacy of over 30%.1 Although this figure was not yet ideal …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial